Synergistic cytotoxic effects of bortezomib and CK2 inhibitor
CX-4945 in acute lymphoblastic leukemia: turning off the
prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic
NF-κB
- Publication date
- 1 January 2016
- Publisher
- 'Impact Journals, LLC'